Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
COPD Exacerbation clinical trials
1 of 4 indexed COPD Exacerbation trials are currently recruiting.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
COPD Exacerbation: 4 US clinical trials tracked, 1 recruiting.
COPD Exacerbation is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is University of Tennessee Graduate School of Medicine, running 1 of these trials.
Enrollment posture brief
Registry condition copd-exacerbation
OPEN 1 | RECR 25% | LATE 0 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
COPD Exacerbation lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for COPD Exacerbation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
COPD Exacerbation is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
MGH Institute of Health Professions
NCT06304207
Healthy At Home Pilot
University of Massachusetts, Worcester
NCT06000696
Increasing Adherence to Pulmonary Rehabilitation After COPD Related Hospitalizations (Pilot Study)
Mayo Clinic
NCT03865329
COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers
University of Tennessee Graduate School of Medicine
NCT02291016
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on COPD Exacerbation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on COPD Exacerbation trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this COPD Exacerbation page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 COPD Exacerbation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Tennessee Graduate School of Medicine sponsors the most COPD Exacerbation trials on record, review their full trial history before evaluating a specific study. See University of Tennessee Graduate School of Medicine's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This COPD Exacerbation condition card totals 4 registered trials; most-linked intervention Intervention- Home-based Pulmonary Rehabilitation; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.